Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Hydroxychloroquine on Proteinuria and Inflammatory Markers in Chronic Glomerulopathy
TCTR20250319019Phase 2Completed
- Sponsor
- Phramongkutklao Hospital
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in chronic glomerulonephritis (CGN), sponsored by Phramongkutklao Hospital. Started Apr 2024; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
chronic glomerulonephritis (CGN)
Beyond the preview
Go deeper on TCTR20250319019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250319019.